
New York Biotechnology Association Gears Up for its 21st Annual Meeting
New York Biotechnology Association (NYBA) will develop its Emerging Companies Showcase at the NYBA 21st Annual Meeting, May 2 in New York City at the Marriott Marquis Hotel.
New York Biotechnology Association (NYBA) will develop its Emerging Companies Showcase at the NYBA 21st Annual Meeting, May 2 in New York City at the Marriott Marquis Hotel.
NeuroMetrix is investigating the impact of intensive Diabetes management on Diabetic Peripheral Neuropathy
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
OneMedPlace is pleased to announce a special interview series exploring current issues facing the diagnostics sector and life sciences.
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes has filed a 510(k), with the FDA for its SENSUS Pain Therapy device.
OneMedRadio recently conducted an interview with Dr. Clifford A. Reid, the company’s President and Chief Executive Officer.
Drug developer AVI Biopharma Inc. said Thursday that Chief Scientific Officer Peter Linsley will resign from the company.
This is Part II of our special report on PTSD, a survey of the rising causes for concern and potential treatments to combat it.
The 5th Annual Vaccine Industry Excellence Awards has named Advaxis as the Best Therapeutic Vaccine for the company’s ADVX-HPV construct.
In this unprecedented age of technology and communication, many wonder why the healthcare industry has traditionally not been on the cutting edge.
Copyright © 2025 | WordPress Theme by MH Themes